Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Evercore Partners Inc (NYSE:EVR) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an EPS of $3.41 against a forecast of $3.04. The company also exceeded revenue ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

Reports Q4 adjusted revenue $980.5M, consensus $883.4M. John Weinberg, Chairman and Chief Executive Officer, “We are pleased with our ...

Wall Street investment bank Evercore ISI (EVR) is pounding the table on Nvidia (NVDA) stock ahead of the chipmaker’s upcoming ...

Fintel reports that on February 13, 2025, Evercore ISI Group downgraded their outlook for Trade Desk (NasdaqGM:TTD) from ...

Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...

Nvidia (NASDAQ:NVDA) was added to Evercore ISI's Tactical Outperform list on Monday as analysts turned bullish ahead of the company's fiscal fourth-quarter earnings report on February 26.

Canada Goose (NYSE:GOOS – Get Free Report) had its price objective dropped by investment analysts at Evercore ISI from $13.00 ...